The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The C7H8N4O2 Drug Master File in Japan (C7H8N4O2 JDMF) empowers C7H8N4O2 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the C7H8N4O2 JDMF during the approval evaluation for pharmaceutical products. At the time of C7H8N4O2 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of C7H8N4O2 suppliers with JDMF on PharmaCompass.